SCHEMBL2692807

SCHEMBL2692807

CC(C)C[C@H](N)C([O])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2692805 1.00 — —
Leucine SCHEMBL4449412 0.81 SLC7A5 (0.95) —
Leucine SCHEMBL4449410 0.81 SLC7A5 (0.95) —
Leucine SCHEMBL5546214 0.79 SLC7A5 (0.90) —
Leucine SCHEMBL5546212 0.79 SLC7A5 (0.90) —
Leucine SCHEMBL25241602 0.78 SLC7A5 (1.00) —
Leucine SCHEMBL8568060 0.78 SLC7A5 (1.00) —
D-Leucine SCHEMBL9449950 0.78 SLC7A5 (1.00) —
Leucine SCHEMBL2478164 0.78 SLC7A5 (1.00) —
Leucine SCHEMBL175940 0.78 SLC7A5 (1.00) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116891511-A 20 (S) -ginsenoside Rg 2 Amino acid ester derivative, preparation method and application 吉林大学 2023-10-17 — — CN claimed
CN-114380880-A Fmoc-amino acid modified 20(S) -protopanoxadiol derivative, preparation method and application thereof 吉林大学 2022-04-22 — — CN claimed
US-20240156792-A1 COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-05-16 — — US disclosed
US-11918562-B2 Combination therapy using azabicyclo compound for cancer TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-03-05 — — US disclosed
CN-116891511-A 20 (S) -ginsenoside Rg 2 Amino acid ester derivative, preparation method and application 吉林大学 2023-10-17 — — CN disclosed
CN-114380880-B Fmoc-amino acid modified 20 (S) -protopanoxadiol derivative and preparation method and application thereof 吉林大学 2023-06-23 — — CN disclosed
CN-115611872-A Multi-structure-position modified andrographolide derivative and application thereof 南京工业大学 2023-01-17 — — CN disclosed
CN-114380880-A Fmoc-amino acid modified 20(S) -protopanoxadiol derivative, preparation method and application thereof 吉林大学 2022-04-22 — — CN disclosed
US-20220016090-A1 COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER TAIHO PHARMACEUTICAL CO., LTD. (JP) 2022-01-20 — — US disclosed
US-11166943-B2 Combination therapy using azabicyclo compound for cancer TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-11-09 — — US disclosed
WO-2021024393-A1 CANCER COMBINATION THERAPY USING AZABICYCLIC COMPOUND AND POLYADENOSINE-5'-DIPHOSPHATE RIBOSE POLYMERASE INHIBITOR 大鵬薬品工業株式会社 2021-02-11 — — WO disclosed
US-4389524-A Cepham compounds CIBA-GEIGY CORPORATION (US) 1983-06-21 — — US disclosed
US-4319027-A Process for the manufacture of ceohem enol derivatives CIBA-GEIGY CORPORATION (US) 1982-03-09 — — US disclosed
US-4301278-A BY HYDROGENATION IN THE PRESENCE OF A CATALYST CIBA-GEIGY CORPORATION (US) 1981-11-17 — — US disclosed
US-4293462-A Process for the manufacture of enol derivatives, and intermediates CIBA-GEIGY CORPORATION (US) 1981-10-06 — — US disclosed
US-4256739-A 7β-Amino-3-thio-3-cephem-4-carboxylic acid compounds, and antibacterial compositions and methods using them CIBA-GEIGY CORPORATION (US) 1981-03-17 — — US disclosed
US-4255328-A CEPHALOSPORINS CIBA-GEIGY CORPORATION (US) 1981-03-10 — — US disclosed
US-4147864-A Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds CIBA-GEIGY CORPORATION (US) 1979-04-03 — — US disclosed
US-4110533-A PROCESS FOR THE MANUFACTURE OF ENOL DERIVATIVES CIBA-GEIGY CORPORATION (US) 1978-08-29 — — US disclosed
US-4073902-A ANTIMICROBIAL COMPOUNDS CIBA-GEIGY CORPORATION (US) 1978-02-14 — — US disclosed
Send feedback